Amgen (AMGN) Non-Current Deferred Tax Liability (2013 - 2026)

Amgen (AMGN) has reported Non-Current Deferred Tax Liability for 13 consecutive years, with $1.3 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Non-Current Deferred Tax Liability fell 10.99% year-over-year to $1.3 billion; the TTM figure through Mar 2026 stood at $1.3 billion (down 10.99% YoY), while the FY2025 annual figure was $1.4 billion, down 15.47% from the prior year.
• Non-Current Deferred Tax Liability came in at $1.3 billion for Q1 2026 at Amgen, down from $1.4 billion in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $2.4 billion in Q4 2023, with the low at $11.0 million in Q4 2022.
• Average Non-Current Deferred Tax Liability over 5 years is $1.5 billion, with a median of $1.5 billion recorded in 2025.
• Across the five-year window, Non-Current Deferred Tax Liability jumped 21300.0% in 2023 and slumped 31.35% in 2024, its largest moves.
• Year by year, Non-Current Deferred Tax Liability stood at $11.0 million in 2022, then surged by 21300.0% to $2.4 billion in 2023, then plunged by 31.35% to $1.6 billion in 2024, then retreated by 15.47% to $1.4 billion in 2025, then decreased by 1.61% to $1.3 billion in 2026.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $1.3 billion, $1.4 billion, and $1.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.